戻る
Psychemedics Corp (PMDI)価格
PMDI 株価推移チャート
PMDI 収入
Psychemedics Corp
$1.8
9.75%
$0.16
本日現在の状況：Jan 26, 12:05:25 GMT-5
最新の利益結果: Q3 '23
報告済み: 2023-11-09
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
PMDIの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Psychemedics Corp PMDIの前四半期の収益はどうでしたか？
Psychemedics Corpの収益見積もりはいくらですか？
Psychemedics Corpの収益品質スコアはどれくらいですか？
Psychemedics Corpはいつ収益を報告しますか？
Psychemedics Corpの予想収益はいくらですか？
Psychemedics Corpは収益予想を上回りましたか？
主要データ
前終値
$1.64
始値
$1.66
当日レンジ
$1.66 - $1.8
52週レンジ
$1.45 - $2.44
取引高
--
平均取引高
2.1K
1株当たり利益(TTM)
-0.32
配当利回り
0.00%
時価総額
$10.9M
PMDIとは何ですか？
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 101 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The firm markets its corporate drug testing services through its own sales force, distributors, and partners. The company markets its home drug testing service, PDT-90, through the Internet.